IP Library Assignment 055657/0911
Patent Assignment
Reel/Frame 055657/0911

Release of Security Interest

Recorded: 2021-03-19 Pages: 15
Assignor
Assignee
BIODESIX, INC.
2970 WILDERNESS PLACE, SUITE 100, BOULDER, COLORADO, 80301
Covered Properties (39)
Method for treating and identifying lung cancer patients likely to benefit from EGFR inhibitor and a monoclonal antibody HGF inhibitor combination therapy
Application: 14/678,428 →
Publication: US 2015/0285817
Deep MALDI TOF Mass Spectrometry of Complex Biological Samples, e.g., Serum, and Uses Thereof
Patent: 9,606,101 →
Application: 14/868,575 →
Publication: US 2016/0018410
Treatment selection for lung cancer patients using mass spectrum of blood-based sample
Application: 14/868,615 →
Publication: US 2016/0019342
Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF Mass Spectrometry
Application: 14/936,847 →
Publication: US 2016/0163522
Predictive test for prognosis of myelodysplastic syndrome patients using mass spectrometry of blood-based sample
Application: 14/946,045 →
System and Method for Three-Dimensional Nerve Segmentation Using Curved Multiplanar Reformatting Magnetic Resonance Imaging
Patent: 9,971,952 →
Application: 15/019,417 →
Publication: US 2016/0232664
Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
Application: 15/207,825 →
Publication: US 2017/0039345
Predictive Test for Aggressiveness or Indolence of Prostate Cancer from Mass Spectrometry of Blood-Based Sample
Application: 15/701,668 →
Publication: US 2018/0129780
Diagnostic Test Stystem for Specific, Sensitive and Reproducible Detection of Circulating Nucleic Acids in Whole Blood
Application: 15/862,896 →
Publication: US 2018/0202005
Method for Identification of Cancer Patients with Durable Benefit from Immunotherapy in Overall Poor Prognosis Subgroups
Application: 62/442,557 →
Diagnostic Test Stystem for Specific, Sensitive and Reproducible Detection of Circulating Nucleic Acids in Whole Blood
Application: 62/442,578 →
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Patent: 7,736,905 →
Application: 11/396,328 →
Publication: US 2007/0231921
Method for Reliable Classification of Samples in Clinical Diagnostics Using an Improved Method of Classification
Patent: 8,024,282 →
Application: 12/218,519 →
Publication: US 2008/0306898
Selection of Non-Small-Cell Lung Cancer Patients for Treatment with Monoclonal Antibody Drugs Targeting Egfr Pathway
Patent: 7,858,389 →
Application: 12/321,392 →
Publication: US 2009/0170215
Selection of Head and Neck Cancer Patients for Treatment with Drugs Targeting Egfr Pathway
Patent: 7,867,775 →
Application: 12/321,393 →
Publication: US 2009/0171872
Selection of Colorectal Cancer Patients for Treatment with Drugs Targeting Egfr Pathway
Patent: 7,858,390 →
Application: 12/321,394 →
Publication: US 2009/0170216
Monitoring Treatment of Cancer Patients with Drugs Targeting Egfr Pathway Using Mass Spectrometry of Patient Samples
Patent: 7,906,342 →
Application: 12/584,594 →
Publication: US 2010/0055100
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Patent: 7,879,620 →
Application: 12/661,129 →
Publication: US 2010/0204061
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Patent: 9,824,182 →
Application: 12/806,137 →
Publication: US 2010/0305868
Monitoring Treatment of Head and Neck Cancer Patients with Drugs Egfr Pathway Using Mass Spectrometry of Patient Samples
Patent: 8,119,417 →
Application: 12/931,322 →
Publication: US 2011/0121168
Monitoring Treatment of Colorectal Cancer Patients with Drugs Targeting Egfr Pathway Using Mass Spectrometry of Patient Samples
Patent: 8,119,418 →
Application: 12/931,324 →
Publication: US 2011/0121169
Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
Patent: 8,586,379 →
Application: 13/313,791 →
Publication: US 2012/0074310
Monitoring treatment of Head and Neck cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
Patent: 8,586,380 →
Application: 13/313,838 →
Publication: US 2012/0074311
A Method for Predicting Breast Cancer Patient Response to Endocrine Therapy
Patent: 8,914,238 →
Application: 13/356,730 →
Publication: US 2012/0193525
Method and system for determining whether a drug will be effective on a patient with a disease
Patent: 9,152,758 →
Application: 13/373,336 →
Publication: US 2012/0089341
Method and System for Validation of Mass Spectrometer Machine Performance
Patent: 8,467,988 →
Application: 13/733,018 →
A Method for Predicting Breast Cancer Patient Response to Combination Therapy
Patent: 9,254,120 →
Application: 13/741,634 →
Publication: US 2013/0131996
Mass-Spectral Method for Selection, and De-Selection, of Cancer Patients for Treatment with Immune Response Generating Therapies
Patent: 9,653,272 →
Application: 13/835,909 →
Publication: US 2013/0344111
Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agents
Patent: 8,718,996 →
Application: 13/836,064 →
Publication: US 2014/0012514
Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof
Patent: 9,279,798 →
Application: 13/836,436 →
Publication: US 2013/0320203
Treatment selection for lung cancer patients using mass spectrum of blood-based sample
Patent: 9,211,314 →
Application: 14/460,769 →
Publication: US 2015/0283206
Classification Generation Method Using Combination of Mini-Classifiers with Regularization and Uses Thereof
Patent: 9,477,906 →
Application: 14/486,442 →
Publication: US 2015/0102216
Predictive Test for Aggressiveness or Indolence of Prostate Cancer from Mass Spectrometry of Blood-Based Sample
Patent: 9,779,204 →
Application: 14/869,348 →
Publication: US 2016/0098514
Method of predicting development and severity of graft-versus-host disease
Patent: 9,563,744 →
Application: 14/949,229 →
Classifier Generation Methods and Predictive Test for Ovarian Cancer Patient Prognosis Under Platinum Chemotherapy
Predictive Test for Melanoma Patient Benefit from Interleukin-2 (IL2) Therapy
Predictive Test for Melanoma Patient Benefit from Antibody Drug Blocking Ligand Activation of the T-Cell Programmed Cell Death 1 (Pd-1) Checkpoint Protein and Classifier Development Methods
Predictive Test for Aggressiveness or Indolence of Prostate Cancer from Mass Spectrometry of Blood-Based Sample
Method for Identification of Cancer Patients with Durable Benefit from Immunotherapy in Overall Poor Prognosis Subgroups
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 16, 2007
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC., A DELAWARE CORPORATION
Reel/Frame 019021/0827 →
Assignment of Assignor's Interest Aug 12, 2008
From: TSYPIN, MAXIM; ROEDER, HEINRICH
To: BIODESIX, INC.
Reel/Frame 021388/0135 →
Assignment of Assignor's Interest Mar 2, 2009
From: ROEDER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 022348/0985 →
Assignment of Assignor's Interest Mar 2, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 022348/0989 →
Assignment of Assignor's Interest Mar 2, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 022349/0058 →
Assignment of Assignor's Interest Sep 28, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 023301/0428 →
Assignment of Assignor's Interest Nov 9, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 023509/0816 →
Short-Form Patent Security Agreement Dec 3, 2013
From: BIODESIX, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031751/0694 →
Assignment of Assignor's Interest Apr 17, 2015
From: RODER, HEINRICH; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 035435/0539 →
Assignment of Assignor's Interest Sep 29, 2015
From: RÖDER, HEINRICH; ASMELLASH, SENAIT; ALLEN, JENNA; TSYPIN, MAXIM
To: BIODESIX, INC.
Reel/Frame 036679/0992 →
Assignment of Assignor's Interest Sep 29, 2015
From: RÖDER, HEINRICH; RÖDER, JOANNA
To: BIODESIX, INC.
Reel/Frame 036679/0897 →
Assignment of Assignor's Interest Nov 7, 2015
From: HAN, MAY; KOMARNITSKY, PHILIP; GYURIS, JENO
To: AVEO PHARMACEUTICALS, INC.
Reel/Frame 036984/0459 →
Assignment of Assignor's Interest Nov 20, 2015
From: STEINGRIMSSON, ARNI; RÖDER, HEINRICH; RÖDER, JOANNA
To: BIODESIX, INC.
Reel/Frame 037097/0889 →
Assignment of Assignor's Interest Jan 21, 2016
From: RÖDER, JOANNA; OLIVEIRA, CARLOS; GRIGORIEVA, JULIA; RÖDER, HEINRICH
To: BIODESIX, INC.
Reel/Frame 037548/0232 →
Assignment of Assignor's Interest Aug 10, 2016
From: RODER, JOANNA; MEYER, KRISTA; GRIGORIEVA, JULIA; TSYPIN, MAXIM
To: BIODESIX INC.
Reel/Frame 039398/0069 →
Assignment of Assignor's Interest Jan 25, 2017
From: MELLERT, HESTIA; JACKSON, LEISA; PESTANO, GARY A.
To: BIODESIX, INC.
Reel/Frame 041085/0166 →
Assignment of Assignor's Interest Feb 24, 2017
From: OLIVEIRA, CARLOS; RODER, HEINRICH; GRIGORIEVA, JULIA; RODER, JOANNA
To: BIODESIX INC.
Reel/Frame 041366/0056 →
Assignment of Assignor's Interest Sep 12, 2017
From: RODER, JOANNA; RODER, HEINRICH; OLIVEIRA, CARLOS
To: BIODESIX INC.
Reel/Frame 043559/0436 →
Assignment of Assignor's Interest Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044813/0947 →
Assignment of Assignor's Interest Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044815/0024 →
Assignment of Assignor's Interest Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044816/0809 →
Assignment of Assignor's Interest Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044818/0967 →
Assignment of Assignor's Interest Feb 5, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044831/0038 →
Assignment of Assignor's Interest Feb 5, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044831/0024 →
Assignment of Assignor's Interest Feb 5, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044831/0010 →